INTELLIGENT BIO SOLUTIONS INC.
INBS · XNASCIK 1725430fmd_0MEC8SFSB76W0BFQM4GCXJV0BQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jul 01, 2019 to Sep 30, 2026, 29 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 2 | 0 | 1 | 3 | 3 | 4 |
| Cost of revenue | – | – | – | 1 | 2 | 2 | 2 |
| Realized investment gains (losses) | 0 | (0) | – | – | – | – | – |
| Gross profit | – | – | – | 0 | 1 | 1 | 2 |
| Selling, general and administrative | – | – | – | – | – | 9 | 11 |
| Total operating expenses | 3 | 8 | 9 | 14 | 12 | 13 | 15 |
| Operating income | (3) | (6) | (8) | (13) | (10) | (11) | (13) |
| Interest expense | – | – | – | – | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | (1) | 0 | 2 | 0 | 0 | 0 |
| Income before taxes | (3) | (7) | – | – | – | – | – |
| Net income | (3) | (7) | (8) | (11) | (10) | (11) | (12) |